<?xml version='1.0' encoding='utf-8'?>
<document id="15822193"><sentence text="Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs." /><sentence text="Recent studies have revealed the import role played by transporters in the renal and hepatobiliary excretion of many drugs" /><sentence text=" These transporters exhibit a broad substrate specificity with a degree of overlap, suggesting the possibility of transporter-mediated drug-drug interactions with other substrates" /><sentence text=" This review is an overview of the roles of transporters and the possibility of transporter-mediated drug-drug interactions" /><sentence text=" Among the large number of transporters, we compare the Ki values of inhibitors for organic anion transporting polypeptides (OATPs) and organic anion transporters (OATs) and their therapeutic unbound concentrations" /><sentence text=" Among them, cephalosporins and probenecid have the potential to produce clinically relevant OAT-mediated drug-drug interactions, whereas cyclosporin A and rifampicin may trigger OATP-mediated ones"><entity charOffset="13-27" id="DDI-PubMed.15822193.s6.e0" text="cephalosporins" /><entity charOffset="32-42" id="DDI-PubMed.15822193.s6.e1" text="probenecid" /><entity charOffset="138-151" id="DDI-PubMed.15822193.s6.e2" text="cyclosporin A" /><entity charOffset="156-166" id="DDI-PubMed.15822193.s6.e3" text="rifampicin" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e0" e2="DDI-PubMed.15822193.s6.e0" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e0" e2="DDI-PubMed.15822193.s6.e1" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e0" e2="DDI-PubMed.15822193.s6.e2" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e0" e2="DDI-PubMed.15822193.s6.e3" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e1" e2="DDI-PubMed.15822193.s6.e1" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e1" e2="DDI-PubMed.15822193.s6.e2" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e1" e2="DDI-PubMed.15822193.s6.e3" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e2" e2="DDI-PubMed.15822193.s6.e2" /><pair ddi="false" e1="DDI-PubMed.15822193.s6.e2" e2="DDI-PubMed.15822193.s6.e3" /></sentence><sentence text=" These drugs have been reported to cause drug-drug interactions in vivo with OATs or OATP substrates, suggesting the possibility of transporter-mediated drug-drug interactions" /><sentence text=" To avoid adverse consequences of such transporter-mediated drug-drug interactions, we need to be more aware of the role played by drug transporters as well as those caused by drug metabolizing enzymes" /><sentence text="" /></document>